Day: November 18, 2022

TORONTO, Nov. 18, 2022 (GLOBE NEWSWIRE) — Shawcor Ltd. (“Shawcor” or the “Company”) (TSX: SCL) announced that it has sold its Oilfield Asset Management (“OAM”) operating unit to Force Inspection Services Inc. (“Force”), in a transaction generating at least C$15 million in gross proceeds. Shawcor will retain OAM related Western Canadian real-estate assets which it may elect to sell at a future date. As part of the transaction, Shawcor has agreed to lease these properties to Force. The OAM business, reported within the Company’s Composite Systems (“CS”) segment, is a provider of downhole tubular inspection, repair and inventory management services to the Western Canadian energy market. It generated revenue of approximately C$38.1 million with an adjusted EBITDA of approximately C$5.3 million in the first nine months of 2022. Proceeds...

BBS-Bioactive Bone Substitutes Oyj, Company release, 18 November 2022 at 2.30 p.m. EET BBS-Bioactive Bone Substitutes Oyj (BBS) organized a rights issue from May 18 to June 3, 2022. In connection with the share issue, a total of 670,962 warrants from two different series (TO1 and TO2) were also granted to the subscribers. Each warrant gives its owner the right to subscribe for one new share at a discounted price. Information about the first series of warrants (TO1):Subscription period: For the first warrant series (TO1), the subscription period starts on Monday 21 November 2022 and ends on Friday 2 December 2022. Place of subscription: The subscription place in Finland is the account and asset managers and in Sweden Hagberg & Aneborn Fondkomission AB. The subscription order must be given in accordance with the instructions given...

BBS-Bioactive Bone Substitutes Oyj, Company release, Inside Information, 18 November 2022 at 2.30 p.m. EET The Notified Body has completed its first audit (15-18 November 2022) and has delivered its audit report to the company. The audit was focused on the quality system of BBS-Bioactive Bone Substitutes Oyj (BBS), and it was a part of the CE marking process of the company’s first product (ARTEBONE® Paste bone filler). During the authorities’ first audit, the Notified Body inspected documentation related to the quality system. No critical non-conformities related to the quality system were reported during the audit and the CE marking approval process may thus proceed as planned. “We are very pleased with the results of the audit. We have been successful in developing our quality system further, as the audit revealed only minor non-conformities,...

Phase 2 clinical trial investigating KP1077 in patients with IH expected to initiate prior to year-end 2022 CELEBRATION, Fla., Nov. 18, 2022 (GLOBE NEWSWIRE) — KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a biotechnology company focused on the discovery, development and commercialization of novel treatments for rare central nervous system (CNS) and neurodegenerative diseases, lysosomal storage disorders and related treatment areas, today announced that the U.S. Food and Drug Administration (FDA) has granted the Orphan Drug Designation to serdexmethylphenidate (SDX), KemPharm’s proprietary prodrug of d-methylphenidate (d-MPH), for the treatment of idiopathic hypersomnia (IH), a rare neurological sleep disorder. SDX is the sole active pharmaceutical ingredient (API) in KP1077, KemPharm’s lead clinical candidate being...

Toronto, Nov. 18, 2022 (GLOBE NEWSWIRE) — Gulf & Pacific Equities Corp. (TSX-V: GUF) an established company focused on the acquisition, management and development of anchored shopping centres in Western Canada, reports a 3.5% decrease in revenues to $992,940 in the quarter ended September 30, 2022 from $1,029,139 at the same period last year. Details of the nine and three months financial results for fiscal 2022 and 2021 under International Financial Reporting Standards (IFRS) as summarized below are also available at www.sedar.com or the company’s website www.gpequities.com.  Nine Months Ended   Three Months Ended  (Unaudited)   (Unaudited)  Sept 30,   Sept 30,    2022     2021     2022   2021           Revenue $ 2,940,635   $ 2,901,882   $ 992,940 $ 1,029,139           Net Income (loss) before fair...

Sudhanshu Priyadarshi Wabash announces the appointment of Sudhanshu Priyadarshi to the company’s Board of Directors.LAFAYETTE, Ind., Nov. 18, 2022 (GLOBE NEWSWIRE) — Wabash (NYSE: WNC) and its Board of Directors are pleased to announce the appointment of Sudhanshu Priyadarshi to the company’s Board of Directors. Mr. Priyadarshi is a global finance and operations leader with extensive experience in the tech, logistics, e-commerce, retail, consumer packaged goods, and pharmaceutical industries in the U.S., Asia and Australia. He currently serves as Chief Financial Officer at Keurig Dr Pepper. Prior to joining Keurig Dr Pepper, he was Senior Vice President and Chief Financial Officer at Vista Outdoor, Inc., a leading global designer, manufacturer and marketer of consumer products in the outdoor sports and recreation markets. His...

Harvia Plc                                      Stock Exchange Release          18 November 2022 at 1:30 p.m. EETIn Harvia’s English stock exchange release regarding Tapio Pajuharju’s decision to leave Harvia, published on 17 November 2022 at 4:30 pm EET, there was an error regarding the date of the stock exchange release (11 November 2022). The correct date of the release is 17 November 2022. The date was correct in the Finnish version.For more information, please contact: Ari Vesterinen, CFO, tel. +358 40 5050 440Harvia is one of the leading companies operating in the sauna and spa market globally, as measured by revenue. Harvia’s brands and product portfolio are well known in the market, and the company’s comprehensive product portfolio strives to meet the needs of the international sauna and spa market of both private and professional...